BioRestorative Therapies Inc., a fully integrated regenerative medicine company, has released an investor presentation detailing its ongoing projects and leadership team. The presentation highlights the company's focus on developing stem cell-based therapies, including brown adipose-derived stem cells and bone marrow-derived mesenchymal stem cells. These initiatives are in various stages, from preclinical to mid-stage clinical development. The presentation also outlines the company's work on Secretome, a biologics-based technology for cosmetic applications. Lance Alstodt serves as the Chairman and CEO, while Francisco Silva is the Vice President of R&D, bringing extensive experience in stem cell research and development. You can access the full presentation through the link below.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。